Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study

Table 1

Proportion of the 17 participating hospitals that adhere to specific recommendations for treatment of hyperemesis gravidarum (HG) issued by the Norwegian Society for Obstetrics and Gynecology (NGF) in 2014.

Assessment and fluids	Number (%)
PUQE-24^a recommended to assess and monitor symptoms	16 (94)
Intravenous fluid replacement	17 (100)
Antiemetic medication treatment pathway
Equivalent to the NGF guideline	7 (41)
Slightly different treatment pathway from the NGF guideline^b	8 (47)
Differs from the NGF guideline^c	2 (11)
Thiamine and nutrition
Thiamine if persistent vomiting for two weeks or more	17 (100)
Partial peripheral nutrition for a limited period of time	13 (76)
Enteral tube feeding if lack of improvement and weight loss	16 (94)
Total parenteral nutrition if tube feeding fails	16 (94)

^aPUQE-24: Pregnancy Unique Quantification of Emesis, evaluated for the last 24 hours. ^bSame antiemetics, but different, fewer, or not steps defined in the treatment pathway. ^cPromethazine (n = 1). Metoclopramide and levomepromazine, PUQE score, and nutritional treatment not mentioned (n = 1).